Indirect comparison for Anti-TNF drugs in moderate to severe ulcerative colitis
Objective: To compare the relative efficacy of infliximab, adalimumab and golimumab through adjusted indirect treatment comparisons (ITCs). Methods: An exhaustive search was performed until October 2013. Databases consulted were MEDLINE, EMBASE, the Cochrane Library, the Centre for Reviews and Disse...
Saved in:
Main Authors: | M. Galván-Banqueri, M. D. Vega-Coca, M. A. Castillo-Muñoz, C. Beltrán Calvo, T. Molina López |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-01-01
|
Series: | Farmacia Hospitalaria |
Subjects: | |
Online Access: | http://www.aulamedica.es/fh/pdf/8218.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Predictors of infliximab efficacy in patients with severe attack of ulcerative colitis
by: A. O. Golovenko, et al.
Published: (2013-10-01) -
Risk of tuberculosis disease in patients receiving TNF-α antagonist therapy: A meta-analysis of randomized controlled trials
by: Fatemeh Khelghati, et al.
Published: (2024-12-01) -
What to do when traditional rescue therapies fail in acute severe ulcerative colitis
by: Christopher F. D. Li Wai Suen, et al.
Published: (2024-10-01) -
Disease activity, quality of life, and indirect costs of ulcerative colitis in Poland
by: Paweł Kawalec, et al.
Published: (2017-03-01) -
Involvement of HLADQA1*05 in Patients with Inflammatory Bowel Disease Treated with Anti-TNF Drugs
by: Anna Pau, et al.
Published: (2025-01-01)